D
PharmaCorp Rx Inc. PCRX.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 65.72% 1.33% -117.74% -664.47% -721.34%
Total Depreciation and Amortization 2,700.61% -- -- -- --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 2,890.00% -- -- -- --
Change in Net Operating Assets -95.57% 756.66% 1,504.18% -484.43% 2,050.36%
Cash from Operations 152.93% 162.51% 118.08% -464.50% -365.03%
Capital Expenditure -30,898.00% -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -22,071.67% -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -27,012.87% -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -1,161.44% -- -- -- --
Issuance of Common Stock -61.54% 352,351.28% 98,789.21% 98,789.21% 71,322.66%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -62.34% 344,658.62% 97,139.32% 97,316.50% 70,284.95%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -161.93% 1,827.52% 2,307.46% 12,207.96% 15,162.94%